Literature DB >> 22748861

[Psychostimulants in the treatment of depression].

Raphaëlle Richieri1, Marc Adida, Laurent Boyer, Christophe Lançon.   

Abstract

Psychostimulants promote alertness and reduce fatigues that have suggested their use in the treatment of depressive disorders in the early part of the 20th century. Overall, data support the use of psychostimulants in depression particularly in cases of drug resistance, when there is a severe physical illness or when short-term efficiency is needed, especially in the elderly. Psychostimulants are relatively better tolerated than conventional antidepressants, side effects concern less than 20% of patients. Nevertheless, they have to be prescribed carefully in front of the increased cases of misuse described by the literature and the French national committee of narcotics and psychotropics. Larger randomized, controlled trials with longer follow-up periods are needed to clarify a profile of response to psychostimulants, and assess the risk of developing tolerance or dependence on these substances.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22748861     DOI: 10.1016/j.lpm.2012.04.020

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  1 in total

1.  Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities.

Authors:  Robert Karoly Chu; Tea Rosic; Zainab Samaan
Journal:  Case Rep Psychiatry       Date:  2017-06-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.